James A Totterdell (James Totterdell)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Reduced Graphene Oxide

Placebo Controlled

Immune Response

Top Venues

ERJ open research

This page only lists publications with an associated author ORCID identifier.

Publications

Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Parveen Fathima, Mark A Jones, Reena D'Souza, James A Totterdell, Nada Andric, Penelope A Abbott, Richard Norman, Kirsten Howard, Wendy Cheng, Alisa E Pedrana, Joseph S Doyle, Jane Davies, Thomas L Snelling
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. Trials 25 (1) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
Gladymar Perez Chacon, Marie J Estcourt, James A Totterdell, Julie A Marsh, Kirsten P Perrett, Dianne E Campbell, Nicholas Wood, Michael Gold, Claire S Waddington, Michael O' Sullivan, Sonia McAlister, Nigel Curtis, Mark Jones, Peter B McIntyre, Patrick G Holt, Peter C Richmond, Thomas L Snelling
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. PLoS medicine 21 (6) (2024)
James A Totterdell, Gladymar Perez Chacon, Marie J Estcourt, Mark Jones, Peter Richmond, Thomas L Snelling, Julie A Marsh
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. Trials 23 (1) (2022)
Pamela J Laird, James A Totterdell, Roz Walker, Anne B Chang, André Schultz
Prevalence of chronic wet cough and protracted bacterial bronchitis in Aboriginal children. ERJ open research 5 (4) (2019)